Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-83 |
Sentence |
denotes |
Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T1 |
0-83 |
Sentence |
denotes |
Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. |
T2 |
84-95 |
Sentence |
denotes |
UNLABELLED: |
T2 |
84-95 |
Sentence |
denotes |
UNLABELLED: |
T3 |
96-212 |
Sentence |
denotes |
Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T3 |
96-212 |
Sentence |
denotes |
Inflammatory bowel diseases (IBDs) are chronic and progressive inflammatory disorders of the gastrointestinal tract. |
T4 |
213-368 |
Sentence |
denotes |
In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T4 |
213-368 |
Sentence |
denotes |
In IBD, protein serological biomarkers could be relevant tools for assessing disease activity, performing early-stage diagnosis and managing the treatment. |
T5 |
369-587 |
Sentence |
denotes |
Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T5 |
369-587 |
Sentence |
denotes |
Using the interleukin-10 knockout (IL-10(-/-)) mouse, a model that develops a time-dependent IBD-like disorder that predominates in the colon; we performed longitudinal studies of circulating protein biomarkers in IBD. |
T6 |
588-806 |
Sentence |
denotes |
Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T6 |
588-806 |
Sentence |
denotes |
Circulating protein profiles in serum samples collected from 30-, 93-, to 135-day-old IL-10(-/-) mice were investigated using two-dimensional differential gel electrophoresis and MALDI-TOF/TOF tandem mass spectrometry. |
T7 |
807-1033 |
Sentence |
denotes |
A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T7 |
807-1033 |
Sentence |
denotes |
A total of 15 different proteins were identified and confirmed by ELISA and Western blot to be differentially accumulated in serum samples from mid- to late-stage IL-10(-/-) mice compared to early non-inflamed IL-10(-/-) mice. |
T8 |
1034-1305 |
Sentence |
denotes |
The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T8 |
1034-1305 |
Sentence |
denotes |
The use of another model of colitis and an extra-intestinal inflammation model validated this biomarker panel and demonstrated that comprised some global inflammatory markers, some intestinal inflammation-specific markers and some chronic intestinal inflammation markers. |
T9 |
1306-1450 |
Sentence |
denotes |
Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T9 |
1306-1450 |
Sentence |
denotes |
Statistical analyses using misclassification error rate charts validated the use of these identified proteins as powerful biomarkers of colitis. |
T10 |
1451-1618 |
Sentence |
denotes |
Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T10 |
1451-1618 |
Sentence |
denotes |
Unlike standard biomarker screening studies, our analyses identified a panel of proteins that allowed the definition of protein signatures that reflect colitis status. |
T11 |
1619-1643 |
Sentence |
denotes |
BIOLOGICAL SIGNIFICANCE: |
T11 |
1619-1643 |
Sentence |
denotes |
BIOLOGICAL SIGNIFICANCE: |
T12 |
1644-1768 |
Sentence |
denotes |
Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T12 |
1644-1768 |
Sentence |
denotes |
Crohn's disease (CD) and ulcerative colitis (UC) are the most common inflammatory bowel diseases (IBDs) occurring in humans. |
T13 |
1769-1870 |
Sentence |
denotes |
The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T13 |
1769-1870 |
Sentence |
denotes |
The major current diagnosis tool is colonoscopy, which is invasive and could lead to false diagnosis. |
T14 |
1871-2006 |
Sentence |
denotes |
The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T14 |
1871-2006 |
Sentence |
denotes |
The emergence of serological biomarkers enables the use of new diagnosis tools such as protein signatures for IBD diagnosis/management. |
T15 |
2007-2178 |
Sentence |
denotes |
Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |
T15 |
2007-2178 |
Sentence |
denotes |
Using 2D-DIGE coupled to mass spectrometry, our longitudinal study in a mouse model of colitis identified a signature of protein biomarkers for specific stages of disease. |